Industry
Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Loading...
Open
16.22
Mkt cap
19B
Volume
7.5M
High
16.63
P/E Ratio
-19.33
52-wk high
19.31
Low
16.16
Div yield
N/A
52-wk low
8.83
Portfolio Pulse from Benzinga Newsdesk
April 22, 2024 | 4:05 pm
Portfolio Pulse from Benzinga Newsdesk
April 19, 2024 | 10:11 am
Portfolio Pulse from Benzinga Newsdesk
April 18, 2024 | 8:09 pm
Portfolio Pulse from Benzinga Newsdesk
April 16, 2024 | 9:33 pm
Portfolio Pulse from Benzinga Newsdesk
April 16, 2024 | 12:18 pm
Portfolio Pulse from Benzinga Newsdesk
April 12, 2024 | 7:47 pm
Portfolio Pulse from Benzinga Newsdesk
April 11, 2024 | 12:38 pm
Portfolio Pulse from Benzinga Newsdesk
April 08, 2024 | 7:14 am
Portfolio Pulse from Benzinga Newsdesk
April 03, 2024 | 12:26 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.